Company Overview
Astellas Pharma Ltd. is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Friday 10 January 1964, so this is a well established company. Astellas Pharma Ltd. has been in business for 62 years and 2 months. The accounts status is full and the accounts are next due on Thursday 31 December 2026.
Registered Address

300 Dashwood Lang Road, Bourne Business Park, Addlestone, KT15 2NX
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameASTELLAS PHARMA LTD.
Company Number00787610
Registered Office Address300 Dashwood Lang Road
 Bourne Business Park
 KT15 2NX
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date10/01/1964
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryFULL
Returns Next Due Date23/03/2017
Returns Last Made Up Date23/02/2016
Directors & Members
Show Resigned
Rowena Borenstein - Director
(Canadian, 56 years old, born September 1970)
Appointed 01 April 2021
 Active
Barnaby McKay - Director
(British, 49 years old, born April 1977)
Appointed 01 January 2026
 Active
Secretaries
Show Resigned
Other Company Directorships
Rowena Borenstein
No companies found
Barnaby McKay
No companies found
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2017 31-Mar-2016
Balance Sheet
Fixed Assets 1,065,000 1,065,000 1,129,000
Current Assets 121,843,000 121,843,000 104,910,000
Creditors Due Within One Year 74,592,000 74,592,000 64,711,000
Working Cap 47,251,000 47,251,000 40,199,000
Total Assets Less Current Liabilities 48,316,000 48,316,000 41,328,000
Long-term Liabilities 4,011,000 4,011,000 2,628,000
Net Assets 44,305,000 44,305,000 38,700,000
Share Capital & Reserves
Share Cap 11,200,000 11,200,000 11,200,000
Profit & Loss Reserves 33,105,000 33,105,000 27,500,000
Other Reserves 0 0 0
Shareholders Funds 44,305,000 44,305,000 38,700,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2017 31-Mar-2016
Tangible Fixed Assets - - -
Fixed Assets 0.9% 0.9% 1.1%
Stocks Inventory 46.1% 46.1% 42.0%
Debtors 34.3% 34.3% 55.0%
Cash Bank In Hand 0.0% 0.0% 0.0%
Current Assets 99.1% 99.1% 98.9%
Creditors Due Within One Year 60.7% 60.7% 61.0%
Net Current Assets Liabilities 38.4% 38.4% 37.9%
Creditors Due After One Year 3.3% 3.3% 2.5%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 36.0% 36.0% 36.5%
Called Up Share Capital 9.1% 9.1% 10.6%
Share Capital Allotted Called Up Paid 9.1% 9.1% 10.6%
Profit Loss Account Reserve 26.9% 26.9% 25.9%
Shareholder Funds 36.0% 36.0% 36.5%
Capital Employed - - -
Total Assets Less Current Liabilities 39.3% 39.3% 39.0%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2017 31-Mar-2016
Liquidity Ratio 1.6 1.6 1.6
Solvency Ratio 1.6 1.6 1.6
Reserves to Assets 0.3 0.3 0.3
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2017 31-Mar-2016
Assets 122,908,000 122,908,000 106,039,000
Debt 78,603,000 78,603,000 67,339,000
Net Assets/Debt 44,305,000 44,305,000 38,700,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. The balance sheet indicates the net assets of a good sized company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. The balance sheet indicates the net assets of a good sized company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. The balance sheet indicates the net assets of a good sized company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around KT15 2NX
RACAL-NORSK LIMITED
350 Longwater Avenue, Reading, KT15 2NX
NCIPHER CORPORATION LIMITED
350 Longwater Avenue, Green Park, Reading, KT15 2NX
Document Filings
Appointment of Mrs Sandra Patricia Ramirez as a director on 1 January 2026
Confirmation statement made on 23 February 2026 with no updates
Appointment of Mr Barnaby George Robert Mckay as a director on 1 January 2026
Termination of appointment of Jacqueline Sarah Davis as a director on 1 January 2026
Termination of appointment of Martin Anthony Read as a director on 30 June 2025
Confirmation statement made on 23 February 2025 with no updates
Termination of appointment of Yagnaram Santharam as a director on 30 September 2024
Confirmation statement made on 23 February 2024 with no updates
Director's details changed for Mrs Jacqueline Sarah Williams on 4 December 2023
Confirmation statement made on 23 February 2023 with no updates
Registered office address changed from Space 68 Chertsey Road Woking Surrey GU21 5BJ United Kingdom to 300 Dashwood Lang Road Bourne Business Park Addlestone KT15 2NX on 5 December 2022
Appointment of Mr Yagnaram Santharam as a director on 9 September 2022
Termination of appointment of Dilek Aldemir-Cevik as a director on 8 September 2022
Confirmation statement made on 23 February 2022 with no updates
Notification of Astellas Pharma Europe Ltd. as a person with significant control on 6 April 2016
Cessation of Astellas Pharma Inc. as a person with significant control on 23 February 2022
Appointment of Ms Rowena Borenstein as a director on 1 April 2021
Appointment of Dr Martin Anthony Read as a director on 1 April 2021
Confirmation statement made on 23 February 2021 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free